Clincial Coordinating Center for Feasibility Studies ON-268996140-268096140


NIH 2006 N01 HR	Clincial Coordinating Center for Feasibility Studies ON-268996140-268096140 / University of Minnesota Twin Cities
NIH 2005 N01 HR	Clincial Coordinating Center for Feasibility Studies ON-268996140 / University of Minnesota Twin Cities
NIH 2004 N01 HR	Feasibility of Retinoic Acid Treatment in Emphysema /Forte/-N01HR9614 / University of Minnesota Twin C
NIH 2003 N01 HR	Clincial Coordinating Center for Feasibility Studies ON-268996140 / University of Minnesota Twin C
NIH 2002 N01 HR	Clincial Coordinating Center for Feasibility Studies ON-268996140 / University of Minnesota Twin C
NIH 2000 N01 HR	Clincial Coordinating Center for Feasibility Studies ON Connett, John E. / University of Minnesota Twin Cities	$149,131
NIH 2000 N01 HR	Clincial Coordinating Center for Feasibility Studies ON Connett, John E. / University of Minnesota Twin Cities	$968,678
NIH 1999 N01 HR	Clincial Coordinating Center for Feasibility Studies ON Connett, John E. / University of Minnesota Twin Cities

Pragman, Alexa A; Kim, Hyeun Bum; Reilly, Cavan S et al. (2012) The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7:e47305

D'Armiento, Jeanine M; Scharf, Steven M; Roth, Michael D et al. (2009) Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res 10:113

Muindi, Josephia R; Roth, Michael D; Wise, Robert A et al. (2008) Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients. J Clin Pharmacol 48:96-107

Roth, Michael D; Connett, John E; D'Armiento, Jeanine M et al. (2006) Feasibility of retinoids for the treatment of emphysema study. Chest 130:1334-45